Israel Englander Bio Techne Corp Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Bio Techne Corp stock. As of the latest transaction made, Millennium Management LLC holds 1,271,941 shares of TECH stock, worth $92.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,271,941

Previous 30,000 4139.8%

Holding current value

$92.9 Million

Previous $2.15 Million 4629.64%

% of portfolio

0.05%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$70.96 - $82.35 $10.5 Million - $12.1 Million	147,395 Added 13.11%	1,271,941 $102 Million
Q2 2024 Aug 14, 2024	SELL	$62.12 - $84.15 $1.55 Million - $2.1 Million	-24,939 Reduced 2.17%	1,124,546 $80.6 Million
Q1 2024 May 15, 2024	BUY	$65.98 - $77.09 $75.6 Million - $88.3 Million	1,145,501 Added 28752.54%	1,149,485 $80.9 Million
Q4 2023 Feb 14, 2024	SELL	$52.83 - $78.22 $1.94 Million - $2.87 Million	-36,698 Reduced 90.21%	3,984 $307,000
Q2 2023 Aug 14, 2023	SELL	$73.76 - $85.98 $54.2 Million - $63.2 Million	-735,271 Reduced 94.76%	40,682 $3.32 Million
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $30.5 Million - $36.9 Million	426,107 Added 121.8%	775,953 $57.6 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $22.9 Million - $100 Million	283,878 Added 430.33%	349,846 $29 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $16.7 Million - $23.1 Million	59,066 Added 855.78%	65,968 $18.7 Million
Q2 2022 Aug 15, 2022	BUY	$322.67 - $449.65 $1.64 Million - $2.28 Million	5,069 Added 276.54%	6,902 $2.39 Million
Q1 2022 May 16, 2022	SELL	$353.85 - $487.79 $18 Million - $24.8 Million	-50,796 Reduced 96.52%	1,833 $794,000
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $19.6 Million - $22.6 Million	-42,961 Reduced 44.94%	52,629 $27.2 Million
Q3 2021 Nov 15, 2021	BUY	$444.87 - $538.88 $38.5 Million - $46.6 Million	86,547 Added 957.06%	95,590 $46.3 Million
Q2 2021 Aug 16, 2021	SELL	$387.35 - $450.26 $67.1 Million - $78 Million	-173,158 Reduced 95.04%	9,043 $4.07 Million
Q1 2021 May 17, 2021	BUY	$314.62 - $411.0 $36.6 Million - $47.8 Million	116,243 Added 176.24%	182,201 $69.6 Million
Q4 2020 Feb 16, 2021	BUY	$246.9 - $321.87 $1.96 Million - $2.56 Million	7,951 Added 13.71%	65,958 $20.9 Million
Q3 2020 Nov 16, 2020	BUY	$232.22 - $282.96 $11.8 Million - $14.4 Million	50,846 Added 710.04%	58,007 $14.4 Million
Q2 2020 Aug 14, 2020	SELL	$185.43 - $279.56 $271,654 - $409,555	-1,465 Reduced 16.98%	7,161 $1.89 Million
Q1 2020 May 14, 2020	BUY	$161.17 - $221.51 $289,783 - $398,274	1,798 Added 26.33%	8,626 $1.64 Million
Q4 2019 Feb 14, 2020	SELL	$189.68 - $222.09 $13.7 Million - $16 Million	-72,257 Reduced 91.37%	6,828 $1.5 Million
Q3 2019 Nov 14, 2019	SELL	$183.56 - $216.72 $8.54 Million - $10.1 Million	-46,513 Reduced 37.03%	79,085 $15.5 Million
Q2 2019 Aug 14, 2019	SELL	$188.72 - $215.43 $15.9 Million - $18.2 Million	-84,433 Reduced 40.2%	125,598 $26.2 Million
Q1 2019 May 14, 2019	BUY	$136.09 - $200.44 $28.1 Million - $41.4 Million	206,719 Added 6241.52%	210,031 $41.7 Million
Q4 2018 Feb 14, 2019	SELL	$132.75 - $203.8 $10.5 Million - $16.1 Million	-78,782 Reduced 95.97%	3,312 $479,000
Q3 2018 Nov 14, 2018	BUY	$147.44 - $204.11 $12.1 Million - $16.8 Million	82,094 New	82,094 $16.8 Million
Q2 2018 Aug 14, 2018	SELL	$144.9 - $165.58 $10.2 Million - $11.6 Million	-70,053 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$131.46 - $151.04 $191,405 - $219,914	1,456 Added 2.12%	70,053 $10.6 Million
Q4 2017 Feb 14, 2018	SELL	$121.17 - $134.75 $10.1 Million - $11.2 Million	-83,238 Reduced 54.82%	68,597 $8.89 Million
Q3 2017 Nov 14, 2017	BUY	$113.59 - $123.78 $17.2 Million - $18.8 Million	151,835	151,835 $18.4 Million

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.86B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account